h-header

news

News dal mondo

17

Mar

EMA Management Board: highlights of March 2026 meeting

Board adopts Agency’s 2025 annual report and notes electronic product information implementation roadmap

  • EMA annual report 2025

  • Preparations for implementation of the new EU pharmaceutical legislation

  • Electronic product information implementation roadmap

  • EMA reports on stakeholder engagement activities 2024-2025

  • Monitoring EMA’s independence policies

  • Impact of war in the Middle East

  • Executive Director vacancy notice

  • Clinical trials in the EU

23

Apr

Top Drugs at Risk of Supply Shortages

Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...

23

Apr

Regulatory considerations for pharmaceutical excipient selection

The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...

21

Apr

TGA clarifies therapeutic goods are unaffected by chemical production and import ban

TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...

20

Apr

US FDA Draft Guidance on Establishing Impurity Specifications for Antibiotics

FDA issued the draft guidance for industry, Establishing Impurity Specifications for Antibiotics. This...

slider-banner

h-footer